Abstract
A statistically significant association between a silent mutation (102T/C) in the serotonin-2A (5-HT2A) receptor gene and schizophrenia has recently been reported in a sample of Japanese patients and healthy controls. This finding suggests that genetic predisposition to schizophrenia may be affected by a functional 5-HT2A receptor variant that is in linkage disequilibrium with 102T/C. In the present study, we have sought to identify genetic variation in the 5-HT2A receptor gene by screening genomic DNA samples from 91 unrelated subjects comprising 45 patients with schizophrenia and 46 healthy controls by using single-strand conformation analysis. We have identified four nucleotide sequence variants. Two sequence changes would result in protein alterations: a substitution of threonine by asparagine at position 25 (Thr25Asn), and a substitution of histidine by tyrosine at position 452 (His452Tyr). In order to test for a possible contribution to the development of schizophrenia, we have determined allele frequencies in extended samples of unrelated patients and healthy controls. The two amino acid substitutions are found with similar frequencies in patients and controls, indicating that the presence of these variants is not causally related to the development of schizophrenia. However, the reported association of the non-coding polymorphism 102T/C with the disease has also been detected in our sample (P = 0.041, odds ratio = 1.28, 95% confidence interval 1.012–1.623).
Similar content being viewed by others
References
American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders (DSM-III-R) 3rd edn revised. American Psychiatric Press, Washington DC
Arranz M, Collier D, Sodhi M, Ball D, Roberts G, Price J, Sham P, Kerwin R (1995) Association between clozapine response and allelic variation in 5-HT2A receptor gene. Lancet 346: 281–282
Breier A (1995) Serotonin, schizophrenia and antipsychotic drug action. Schizophr Res 14: 187–202
Budowle B, Chakraborty R, Giusti AM, Eisenberg AJ, Allen RC (1991) Analysis of the VNTR locus DIS80 by the PCR followed by high-resolution PAGE. Am J Hum Genet 48:137–144
Chen K, Yang W, Grimsby J, Shih JC (1992) The human 5-HT2 receptor is encoded by a multiple intron-exon gene. Mol Brain Res 14: 20–26
Choi DS, Birraux G, Launay JM, Maroteaux L (1994) The human serotonin 5-HT2B receptor: pharmacological link between 5-HT2 and 5-HT1D receptors. FEBS Letters 352: 393–399
Endicott J, Spitzer RL (1978) A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 35: 837–844
Foguet M, Hoyer D, Pardo LA, Parekh A, Kluxen FW, Kalkman HO, Stühmer W, Lübbert H (1992) Cloning and functional characterization of the rat stomach fundus serotonin receptor. EMBO J 11: 3481–3487
Green SA, Turki J, Innis M, Liggett SB (1994) Amino-terminal polymorphisms of the human β2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 33: 9414–9419
Greenberg DA (1993) Linkage analysis of “necessary” disease loci versus “susceptibility” loci. Am J Hum Genet 52: 135–143
Hallmayer J, Kennedy JL, Wetterberg L, Sjögren B, Kidd KK, Cavalli-Sforza LL (1992) Exclusion of linkage between the serotonin 2 receptor and schizophrenia in a large Swedish kindred. Arch Gen Psychiatry 49: 216–219
Hayashi K, Yandell DW (1993) How sensitive is PCR-SSCP? Human Mutation 2: 338–346
Hsieh CL, Bowcock AM, Farrer LA, Hebert JM, Huang KM, Cavalli-Sforza LL, Julius D, Francke U (1990) The serotonin receptor subtype 2 locus HTR2 is on human chromosome 13 near genes for esterase D and retinoblastoma and on mouse chromosome 14. Somat Cell Genet 16: 567–574
Inayama Y, Yoneda H, Ishida T, Nonomura Y, Kono Y, Koh J, Kuroda K, Higashi H, Asaba H, Sakai T (1994) An association between schizophrenia and a serotonin receptor DNA marker (5HTR2) (abstract) Neuropsychophatmacology 10: 56S
Inayama Y, Yoneda H, Sakai T, Ishida T, Nonomura Y, Kono Y, Takahata R, Koh J, Sakai J, Takai A, Inada Y, Asaba H (1995) Evidence of a positive association between schizophrenia and the serotonin receptor markers. (in preparation)
Julius D, Huang KN, Livelli TJ, Axel R, Jessell TM (1990) The 5HT2 receptor defines a family of structurally distinct but functionally conserved serotonin receptors. Proc Natl Acad Sci USA 87:928–932
Kursar JD, Nelson DL, Wainscott DB, Baez M (1994) Molecular cloning, functional expression, and mRNA tissue distribution of the human 5-hydroxytryptamine2B receptor. Mol Pharmacol 46:227–234
Meltzer HY (1992) The importance of serotonin-dopamine interactions in the action of clozapine. Br J Psychiatry 17:22
Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
Nöthen MM, Fimmers R, Propping P (1993) Association versus linkage studies in psychosis genetics. J Med Genet 30:634–637
Obberghen-Schilling EV, Vouret-Craviari V, Haslam RJ, Chambard J-C, Pouysségur J (1991) Cloning, functional expression and role in cell growth regulation of a hamster 5-HT2 receptor subtype. Mol Endocrinol 5:881–889
Orita M, Suzuki Y, Sekiya T, Hayashi K (1989) Rapid and sensitive detection of point mutations and DNA polymorphisms using polymerase chain reaction. Genomics 5:874–879
Pritchett DB, Bach AWJ, Wozny N, Taleb O, Dal Toso R, Shih JC, Seeberg PH (1988) Structure and functional expression of cloned rat serotonin 5-HT2 receptor. EMBO J 7:4135–4140
Propping P, Nöthen MM (1995) Genetic variation of CNS receptors — a new perspective for pharmacogenetics. Pharmacogenetics 5:318–325
Saltzman AG, Morse B, Whitman MM, Ivanshchenko Y, Jaye M, Felder S (1991) Cloning of the human serotonin 5-HT2 and 5-HT1C receptor subtypes. Biochem Biophys Res Commun 181:1469–1478
Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci USA 74:5463–5467
Schmuck K, Ullmer C, Engels P, Lübbert H (1994) Cloning and functional characterization of the human 5-HT2B serotonin receptor. FEBS 342:85–90
Shih JC, Chen KJ-S, Gallaher TK (1995) Molecular biology of serotonin receptors. A basis for understanding and addressing brain function. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress. Raven Press, New York, pp 407–414
Sleight AJ, Pierce PA, Schmidt AW, Hekmatpanah CR, Peroutka SJ (1991) The clinical utility of serotonin receptor active agents in neuropsychiatric disease. In: Peroutka SJ (ed) Serotonin receptor subtypes. Wiley-Liss, New York, pp 211–227
Wainscott DB, Cohen ML, Schenck KW, Audia JE, Nissen Js, Baez M, Kursar JD, Lucaites VL, Nelson DL (1993) Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine 2F receptor. Mol Pharmacol 43:419–426
Warren JT Jr, Peacock ML, Rodriguez LC, Fink JK (1993) AnMspI polymorphism in the human serotonin receptor gene (HTR2): detection by DGGE and RFLP analysis. Hum Mol Genet 2:338
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Erdmann, J., Shimron-Abarbanell, D., Rietschel, M. et al. Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: Identification of two naturally occurring receptor variants and association analysis in schizophrenia. Hum Genet 97, 614–619 (1996). https://doi.org/10.1007/BF02281871
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02281871